|
|
Ewing Family Of Tumors Cure - Ewing Family Of Tumors Medicine Drug
The Ewing family of tumors is a group of cancers that includes Ewing tumor of bone (ETB or Ewing sarcoma of bone), extraosseous Ewing tumors (EOE tumors), primitive neuroectodermal tumors (PNET or peripheral neuroepithelioma), and Askin tumors (PNET of the chest wall). These tumors all come from the same type of stem cell. Also called EFTs.
Ewing family of tumors (EFT) belong to the group of neoplasms commonly referred to as small, round, blue-cell tumors of childhood. The MIC2 gene product, CD99, is a surface membrane protein that is expressed in most cases of EFT and is useful in suggesting diagnosis of these tumors when the results are interpreted in the context of clinical and pathologic parameters.[1] MIC2 positivity is not unique to EFT, and positivity by immunochemistry is found in several other tumors including synovial sarcoma, non-Hodgkin lymphoma, and gastrointestinal stromal tumors. Concurrent positivity for membrane CD 99 and FL-1 strongly suggest the diagnosis of EFT.[1] The detection of a translocation involving the EWS gene on chromosomes 22 band q12 and any one of a number of partner chromosomes is the key feature in the diagnosis of EFT.[2]
The individual cells of EFT contain round-to-oval nuclei with fine dispersed chromatin without nucleoli. Occasionally, cells with smaller, more hyperchromatic, and probably degenerative nuclei are present giving a light cell/dark cell pattern. The cytoplasm varies in amount, but in the classic case it is clear and contains glycogen, which can be highlighted with a periodic acid-Schiff (PAS) stain. The tumor cells are tightly packed and grow in a diffuse pattern without evidence of structural organization. Tumors with the requisite translocation that show neuronal differentiation are not considered a separate entity, but rather, part of a continuum of differentiation.
Cytogenetic Changes in the Ewing Family of Tumors
Cytogenetic studies of the EFT have identified a consistent alteration of the EWS locus on chromosome 22 band q12 that may involve other chromosomes, including 11 or 21.[3] Characteristically, the amino terminus of the EWS gene is juxtaposed with the carboxy terminus of another gene. In most cases (90%), the carboxy terminus is provided by FLI1, a member of the Ets family of transcription factors gene located on chromosome 11 band q24. Other Ets family members that may combine with the EWS gene in order of frequency are ERG, located on chromosome 21, ETV 1, located on chromosome 7, and E1AF, located on chromosome 17; this results in the following translocations: t(21:22),[4] t(7;22), and t(17;22), respectively. Besides these consistent aberrations involving the EWS gene at 22q12, additional numerical and structural aberrations have been observed in EFTs, including gains of chromosomes 2, 5, 8, 9, 12, and 15, the nonreciprocal translocation t(1;16)(q12;q11.2), and deletions on the short arm of chromosome 6. A molecular test (i.e., reverse transcription polymerase chain reaction [RT-PCR] and restriction analysis of PCR products), currently available on a research basis only, now offers the opportunity of markedly simplifying the definition of the EFT.[5,6] The molecular assay can be performed on relatively small amounts of tissue obtained by minimally invasive biopsies and is capable of providing results faster than cytogenetic analysis.
References:
Parham DM, Hijazi Y, Steinberg SM, et al.: Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior. Hum Pathol 30 (8): 911-8, 1999. Delattre O, Zucman J, Melot T, et al.: The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331 (5): 294-9, 1994. Urano F, Umezawa A, Yabe H, et al.: Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF, available for diagnosis. Jpn J Cancer Res 89 (7): 703-11, 1998. Hattinger CM, Rumpler S, Strehl S, et al.: Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors. Genes Chromosomes Cancer 24 (3): 243-54, 1999. Meier VS, Kühne T, Jundt G, et al.: Molecular diagnosis of Ewing tumors: improved detection of EWS-FLI-1 and EWS-ERG chimeric transcripts and rapid determination of exon combinations. Diagn Mol Pathol 7 (1): 29-35, 1998. Dagher R, Pham TA, Sorbara L, et al.: Molecular confirmation of Ewing sarcoma. J Pediatr Hematol Oncol 23 (4): 221-4, 2001.
|
|
